Font Size: a A A
Keyword [CDK4/6]
Result: 1 - 20 | Page: 1 of 2
1. The Study On The Relationship With Prognosis And Protein Expression Of P16-cylinD1-CDK4/6-pRb In Non-small-cell Lung Cancer
2. The Effect Of CDK4/6 Inhibitor On MicroRNA Expression Profiling In Different Breast Cancer Cell Lines
3. The Inhibitory Effect Of CDK4/6 Inhibitor PD-0332991on ESCC Cells And Its Related Molecular Mechanism
4. The Mechanism Study Of Acquired Resistance Of EGFR-TKIs And Methods To Reverse It In NSCLC
5. Metformin Inhibits M2-like Polarization Of Macrophage And Synergizes The Effect Of CDK4/6 Inhibitors Against Tumor Metastasis
6. Efficacy And Safety Of CDK4/6 Inhibitors Combined With Endocrine Therapy In Advanced Breast Cancer: A Meta-analysis
7. Functional And Molecular Mechamism Study Of Lysine Acetyltransferase 2A And CDK4/CDK6 In Pediatric Acute Lenkemia
8. Anti-liver Cancer Activity And Mechanism Of Glycycoumarin
9. HPV16 E7 Upregulayed The Expression Of ACP5 By Mediating FoxM1 Through Activating CDK6 In Lung Cancer Cells
10. Investigating The Therapeutic Effect Of Olaparib And Palbociclib In Ovarian Cancer And Its Underlying Mechanism
11. The Effect Of Needle Knife Therapy On Cartilage Matrix Degradation And AKT-GSK3 ? And CyclinD1-CDK4/6 Pathways In KOA Rabbits
12. Research Progress Of CDK4/6 Inhibitors In HR+,HER2-advanced Breast Cancer
13. Design, Synthesis And Biological Evaluation Of Aminopyrimidine Derivatives As CDK4/6 Inhibitors
14. Efficacy And Safety Of Molecular Targeted Drugs Combined With Endocrine Drugs In The Treatment Of Breast Cancer:A Meta-analysis
15. Antitumor Activity Of A Novel CDK4/6 Inhibitor,SHR6390,in RB Positive Tumors
16. Screening And Structure–Activity Relationship (SAR) Study Of The Protac-Based Degraders For Target Therapy In Cancers
17. Study Of Cell Proliferation In Acute T Cell Leukemia With High Expression Of Notch1 Gene
18. New Synthetic Method And Anti-Proliferative Activity Study Of Ribociclib And Its Analogues
19. HOTAIR-EZH2 Inhibitor AC1Q3QWB Upregulates CWF19L1 And Enhance Cell Cycle Inhibition Of CDK4/6 Inhibitor Palbociclib In Glioma
20. Enhancement Of Radiosensitivity For Esophageal Squamous Cell Carcinoma By CDK4/6 Inhibitor
  <<First  <Prev  Next>  Last>>  Jump to